159 related articles for article (PubMed ID: 2229772)
1. Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time.
Kus T; Dubuc M; Lambert C; Shenasa M
J Am Coll Cardiol; 1990 Nov; 16(5):1229-37. PubMed ID: 2229772
[TBL] [Abstract][Full Text] [Related]
2. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME
J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
Chilson DA; Heger JJ; Zipes DP; Browne KF; Prystowsky EN
J Am Coll Cardiol; 1985 Jun; 5(6):1407-13. PubMed ID: 3889099
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
5. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ
Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A
Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia.
Shen EN; Sung RJ; Morady F; Schwartz AB; Scheinman MM; DiCarlo L; Shapiro W
J Am Coll Cardiol; 1984 May; 3(5):1291-7. PubMed ID: 6707382
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.
Kus T; Campa MA; Nadeau R; Dubuc M; Kaltenbrunner W; Shenasa M
Am Heart J; 1992 Jan; 123(1):82-9. PubMed ID: 1729853
[TBL] [Abstract][Full Text] [Related]
10. Rate-dependent failure of ventricular capture in patients treated with oral propafenone.
Soriano J; Almendral J; Arenal A; San Román D; Delcan JL; Josephson ME
Eur Heart J; 1992 Feb; 13(2):269-74. PubMed ID: 1555627
[TBL] [Abstract][Full Text] [Related]
11. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
Stark U; Stark G; Kasper K; Schwarzl I; Decrinis M; Pilger E; Tritthart HA
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):43-50. PubMed ID: 9121970
[TBL] [Abstract][Full Text] [Related]
12. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
13. Fractionated endocardial electrograms are associated with slow conduction in humans: evidence from pace-mapping.
Stevenson WG; Weiss JN; Wiener I; Rivitz SM; Nademanee K; Klitzner T; Yeatman L; Josephson M; Wohlgelernter D
J Am Coll Cardiol; 1989 Feb; 13(2):369-76. PubMed ID: 2913115
[TBL] [Abstract][Full Text] [Related]
14. Effect of ajmaline on sustained ventricular tachycardia induced by programmed electrical stimulation in conscious dogs after myocardial infarction.
Todt H; Krumpl G; Zojer N; Krejcy K; Raberger G
Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):290-7. PubMed ID: 7694159
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic and electrophysiologic effects of oral propafenone.
Prystowsky EN; Heger JJ; Chilson DA; Miles WM; Hubbard J; Zipes DP
Am J Cardiol; 1984 Nov; 54(9):26D-28D. PubMed ID: 6496366
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.
Morady F; DiCarlo LA; Krol RB; Baerman JM; de Buitleir M
J Am Coll Cardiol; 1986 Jan; 7(1):148-57. PubMed ID: 3941203
[TBL] [Abstract][Full Text] [Related]
17. Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.
Chiamvimonvat N; Mitchell LB; Gillis AM; Wyse DG; Sheldon RS; Duff HJ
Am J Cardiol; 1992 Sep; 70(6):598-604. PubMed ID: 1324598
[TBL] [Abstract][Full Text] [Related]
18. Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias.
Budde T; Borggrefe M; Podczeck A; Martinez-Rubio A; Breithardt G
J Cardiovasc Pharmacol; 1991 Aug; 18(2):254-60. PubMed ID: 1717787
[TBL] [Abstract][Full Text] [Related]
19. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction.
Stevenson WG; Khan H; Sager P; Saxon LA; Middlekauff HR; Natterson PD; Wiener I
Circulation; 1993 Oct; 88(4 Pt 1):1647-70. PubMed ID: 8403311
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.
Connolly SJ; Kates RE; Lebsack CS; Echt DS; Mason JW; Winkle RA
Am J Cardiol; 1983 Dec; 52(10):1208-13. PubMed ID: 6359849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
